SCHEMBL100205

SCHEMBL100205

CC(C)(C)OC(=O)NCCc1ccc(OCCCc2ccc(-c3ccccc3)c(NC(=O)O)c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.44
NAMPT P43490 1/20 0.43
CA12 O43570 5/20 0.43
CA1 P00915 5/20 0.43
CA2 P00918 5/20 0.43
CA9 Q16790 5/20 0.43
SUCNR1 Q9BXA5 6/20 0.43
PDCD1 Q15116 1/20 0.42
CD274 Q9NZQ7 1/20 0.42
MEN1 O00255 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
KMT2A Q03164 1/20 0.42
BCHE P06276 1/20 0.42
CNR2 P34972 1/20 0.42
PPARG P37231 2/20 0.42
ITGB3 P05106 1/20 0.41
ITGA2B P08514 1/20 0.41
S1PR4 O95977 1/20 0.41
S1PR1 P21453 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15822295 0.93 HPGD (0.45) PDK2NAMPTSUCNR1PDCD1CD274
SCHEMBL15824823 0.85 NAMPT (0.41) PDK2NAMPTCA12CA1CA2
SCHEMBL15824822 0.85 NAMPT (0.41) PDK2NAMPTCA12CA1CA2
SCHEMBL100473 0.85 CHRM3 (0.51)
SCHEMBL13886735 0.84 NPC1 (0.57) NAMPTCA12CA1CA2CA9
SCHEMBL15823262 0.83 NDUFS8 (0.41) PDK2NAMPTSUCNR1PDCD1CD274
SCHEMBL15823264 0.83 NDUFS8 (0.41) PDK2NAMPTSUCNR1PDCD1CD274
SCHEMBL15823923 0.81 FFAR1 (0.47) NPC1RAB9APPARGITGB3ITGA2B
SCHEMBL13886736 0.81 FFAR1 (0.56) CA12CA1CA2CA9MEN1
SCHEMBL15822782 0.80 NAMPT (0.41) PDK2NAMPTCA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2934594-B1 CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES . ALMIRALL SA (ES) 2019-09-04 EP disclosed
EP-2934594-A1 NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITY Almirall, S.A. (ES) 2015-10-28 EP disclosed
WO-2014095920-A1 NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITY ALMIRALL, S.A. (ES) 2014-06-26 WO disclosed
EP-2426121-A1 QUATERNARY AMMONIUM SALT COMPOUND Teijin Pharma Limited (JP) 2012-03-07 EP disclosed